奇奥斯口香糖:对心脏代谢健康的有前途的植物疗法
Sarah A Blomquist1, Maria Luz Fernandez1,2
1School of Nutritional Sciences and Wellness, The University of Arizona, Tucson, AZ 85721, USA.
Nutrients
|September 14, 2024
概括
奇奥斯牙 (CMG) 显示出作为心脏代谢性疾病 (CMD) 的植物治疗药物的潜力. 研究表明,CMG影响脂质和葡萄糖代谢,心血管健康和炎症,为未来的治疗开发提供了基础.
科学领域:
- 植物疗法和自然产品
- 心脏代谢疾病研究研究
- 药理学和生物化学 药理学和生物化学
背景情况:
- (CMG) 是一种来自Pistacia lentiscus的树脂,具有长期的药用历史.
- 最近的兴趣突出了CMG的抗炎和抗氧化特性,在口腔健康,IBD,癌症和心脏代谢风险因素方面有应用.
- 现有研究表明,CMG对心血管和代谢疾病 (CMD) 的潜在益处.
研究的目的:
- 为提供基约斯口香糖的生物活性成分的叙事审查.
- 检查和描述CMG作为心脏代谢性疾病 (CMD) 的植物治疗剂的潜力.
- 综合各种研究类型的证据,以了解CMG在CMD中的作用机制.
主要方法:
- 临床试验,体内,体外和体内研究的综述.
- 对CMG对脂质和葡萄糖代谢影响的证据分析.
- 检查CMG对心血管健康,炎症,氧化应激,身体组成和肠道微生物群的影响.
主要成果:
- 积累的证据支持CMG对关键心脏代谢参数的影响.
- 研究表明,CMG会影响脂质和葡萄糖代谢,心血管和肝脏健康.
- 证据还表明CMG在调节炎症,氧化应激,身体组成和肠道微生物群方面的作用.
结论:
- 尽管研究结果有限,有时不一致,但研究为了解CMG在CMD中的治疗潜力提供了基础.
- 需要进一步的研究来确定CMG及其生物活性物质是心脏代谢疾病的可行的治疗方法.
- 确定优势,弱点和机遇将指导基于CMG的CMD治疗方法的未来发展.
更多相关视频
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
3.9K
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
126
相关概念视频
Cholesterol: Significance and Regulation
519
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
519
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
167
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
167
Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
